Condition

Adenocarcinoma (1)

Chemotherapy (1)

Colon Cancer (1)

Colorectal Neoplasms (1)

Radiation (1)

Solid Tumor (1)

Toripalimab (1)

Overall Status

Recruiting (2)

Terminated (1)

Unknown status (1)

Phase

phase 2 (2)

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute (1)

Harbin Medical University (1)

National University Hospital, Singapore (1)

Zhejiang Cancer Hospital (1)

Study Documents

Intervention Type

drug (4)

device (1)

radiation (1)

Funder Type

Other (4)

Study Type

Interventional (4)

xeliri

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

Recruiting

Toripalimab
Radiation

Toripalimab
+4 more

Hangzhou, Zhejiang, China

Zhengjiang Cancer Hospital

Dec 29, 2022

Solid Tumor Trial in Singapore (CURATE.AI, Capecitabine, XELOX)

Recruiting

Solid Tumor

CURATE.AI
+4 more

Singapore, Singapore
+1 more

Dec 14, 2021

Colorectal Tumors, Chemo Trial in Harbin (XELIRI, XELOX)

Unknown status

Colorectal Neoplasms
Chemotherapy

XELIRI
XELOX

Harbin, Heilongjiang, China

Harbin Medical University

Apr 29, 2018

Adenocarcinoma, Colon Cancer Trial in United States (XELOX, XELIRI, Bevacizumab)

Terminated

Has Results

Adenocarcinoma
Colon Cancer

XELOX
+2 more

Deerfield Beach, Florida
+11 more

Feb 20, 2017